Hydroxyphenyl derivatives with HIV integrase inhibitory properties
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 26, 2002
Issued Date -
N/A
app pub date -
Mar 27, 2000
filing date -
Mar 30, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
An hydroxyphenyl derivative selected from the group consisting of a compound of formula ##STR1## and when a compound of formula I comprises a carboxylic acid group pharmaceutically acceptable salts thereof and when a compound of formula I comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein n is 1, 2 or 3, e is 1, 2 or 3, Hal represents a halogen atom (e.g. Cl, Br, F or I), p is 0, 1 or 2, r is 0, 1 or 2, X and X' each independently represents a single bond, a saturated straight or branched hydrocarbon group of 1 to 4 carbon atoms or a straight or branched hydrocarbon group of 2 to 4 carbon atoms comprising a carbon to carbon double bond, R.sub.a represents H or --CH.sub.3, and R.sub.aa represents H or --CH.sub.3 ; W may represent an amino acid residue or fragment. These compounds may be used to inhibit the activity of HIV integrase.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully